·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ °Çº¸°ø´Ü, MRI º¸ÇèÀû¿ë È«º¸Æ÷½ºÅÍ ¹èÆ÷ ±â»çÀÔ·Â : 05.03.09 17:37:19 0 °¡ ÇÃÄ£Ãß°¡ º¸Çè±Þ¿© Àû¿ë±âÁØ ±Ã±ÝÁõ ÇØ¼Ò...¸®Çø´ 80¸¸ºÎµµ Á¦ÀÛ MRI(ÀÚ±â°ø¸í¿µ»óÁø´Ü)ÀÇ º¸Çè±Þ¿© ±âÁØ¿¡ ´ëÇÑ ±Ã±ÝÁõ ÇØ¼Ò¸¦ À§ÇØ È«º¸Æ÷½ºÅÍ¿Í ¸®Çø´ µîÀÌ Á¦ÀÛ, ¹èÆ÷µÈ´Ù. 9ÀÏ ±¹¹Î°Ç°º¸Çè°ø´ÜÀº MRIÀÇ º¸Çè±Þ¿© Àû¿ë±âÁØ µî¿¡ ´ëÇÑ ±¹¹ÎÀÇ ÀÌÇØ¸¦ µ½±â À§ÇØ È«º¸ Æ÷½ºÅÍ 1,500ºÎ¿Í ¸®Çø´ 80¸¸ºÎ¸¦ Á¦ÀÛÇØ 10ÀϺÎÅÍ ÀÇ·á±â°ü ¹× °ø´ÜÁö»ç µî¿¡ ¹èÆ÷ÇÑ´Ù°í ¹àÇû´Ù. °ø´ÜÀº ¿ÃÇØ 1¿ùºÎÅÍ º¸Çè±Þ¿©°¡ Àû¿ëµÇ´Â 8°³ Ç׸ñ¿¡ ´ëÇÑ ¸ð´ÏÅ͸µÀ» ½Ç½ÃÇÑ °á°ú, MRIÀÇ º¸ÇèÀû¿ë Áúȯ, ºÎÀ§, Ƚ¼ö µî¿¡ ´ëÇÑ ¹®Àǰ¡ °¡Àå ¸¹ÀÚ È«º¸ °È¿¡ ³ª¼¹´Ù. °ø´ÜÀº À̹ø Æ÷½ºÅÍ¿Í ¸®Çø´ ¹èÆ÷·Î ±¹¹ÎÀÇ ±Ã±ÝÁõ ÇØ¼Ò¿Í ÀÇ·á±â°ü ¹Î¿øºÎ´ãÀÌ ÁÙ °ÍÀ¸·Î ¿¹»óÇß´Ù. X AD ²ÜÁ¶ÇÕ Ã£¾Æº¸±â! À̺¥Æ®Âü¿© ¡æ Á¤¿õÁ¾ ±âÀÚ(bulddong@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °Çº¸°ø´Ü, MRI º¸ÇèÀû¿ë È«º¸Æ÷½ºÅÍ ¹èÆ÷ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ °Çº¸°ø´Ü, MRI º¸ÇèÀû¿ë È«º¸Æ÷½ºÅÍ ¹èÆ÷ ±â»çÀÔ·Â : 05.03.09 17:37:19 0 °¡ ÇÃÄ£Ãß°¡ º¸Çè±Þ¿© Àû¿ë±âÁØ ±Ã±ÝÁõ ÇØ¼Ò...¸®Çø´ 80¸¸ºÎµµ Á¦ÀÛ MRI(ÀÚ±â°ø¸í¿µ»óÁø´Ü)ÀÇ º¸Çè±Þ¿© ±âÁØ¿¡ ´ëÇÑ ±Ã±ÝÁõ ÇØ¼Ò¸¦ À§ÇØ È«º¸Æ÷½ºÅÍ¿Í ¸®Çø´ µîÀÌ Á¦ÀÛ, ¹èÆ÷µÈ´Ù. 9ÀÏ ±¹¹Î°Ç°º¸Çè°ø´ÜÀº MRIÀÇ º¸Çè±Þ¿© Àû¿ë±âÁØ µî¿¡ ´ëÇÑ ±¹¹ÎÀÇ ÀÌÇØ¸¦ µ½±â À§ÇØ È«º¸ Æ÷½ºÅÍ 1,500ºÎ¿Í ¸®Çø´ 80¸¸ºÎ¸¦ Á¦ÀÛÇØ 10ÀϺÎÅÍ ÀÇ·á±â°ü ¹× °ø´ÜÁö»ç µî¿¡ ¹èÆ÷ÇÑ´Ù°í ¹àÇû´Ù. °ø´ÜÀº ¿ÃÇØ 1¿ùºÎÅÍ º¸Çè±Þ¿©°¡ Àû¿ëµÇ´Â 8°³ Ç׸ñ¿¡ ´ëÇÑ ¸ð´ÏÅ͸µÀ» ½Ç½ÃÇÑ °á°ú, MRIÀÇ º¸ÇèÀû¿ë Áúȯ, ºÎÀ§, Ƚ¼ö µî¿¡ ´ëÇÑ ¹®Àǰ¡ °¡Àå ¸¹ÀÚ È«º¸ °È¿¡ ³ª¼¹´Ù. °ø´ÜÀº À̹ø Æ÷½ºÅÍ¿Í ¸®Çø´ ¹èÆ÷·Î ±¹¹ÎÀÇ ±Ã±ÝÁõ ÇØ¼Ò¿Í ÀÇ·á±â°ü ¹Î¿øºÎ´ãÀÌ ÁÙ °ÍÀ¸·Î ¿¹»óÇß´Ù. X AD ²ÜÁ¶ÇÕ Ã£¾Æº¸±â! À̺¥Æ®Âü¿© ¡æ Á¤¿õÁ¾ ±âÀÚ(bulddong@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °Çº¸°ø´Ü, MRI º¸ÇèÀû¿ë È«º¸Æ÷½ºÅÍ ¹èÆ÷ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ °Çº¸°ø´Ü, MRI º¸ÇèÀû¿ë È«º¸Æ÷½ºÅÍ ¹èÆ÷ ±â»çÀÔ·Â : 05.03.09 17:37:19 0 °¡ ÇÃÄ£Ãß°¡ º¸Çè±Þ¿© Àû¿ë±âÁØ ±Ã±ÝÁõ ÇØ¼Ò...¸®Çø´ 80¸¸ºÎµµ Á¦ÀÛ MRI(ÀÚ±â°ø¸í¿µ»óÁø´Ü)ÀÇ º¸Çè±Þ¿© ±âÁØ¿¡ ´ëÇÑ ±Ã±ÝÁõ ÇØ¼Ò¸¦ À§ÇØ È«º¸Æ÷½ºÅÍ¿Í ¸®Çø´ µîÀÌ Á¦ÀÛ, ¹èÆ÷µÈ´Ù. 9ÀÏ ±¹¹Î°Ç°º¸Çè°ø´ÜÀº MRIÀÇ º¸Çè±Þ¿© Àû¿ë±âÁØ µî¿¡ ´ëÇÑ ±¹¹ÎÀÇ ÀÌÇØ¸¦ µ½±â À§ÇØ È«º¸ Æ÷½ºÅÍ 1,500ºÎ¿Í ¸®Çø´ 80¸¸ºÎ¸¦ Á¦ÀÛÇØ 10ÀϺÎÅÍ ÀÇ·á±â°ü ¹× °ø´ÜÁö»ç µî¿¡ ¹èÆ÷ÇÑ´Ù°í ¹àÇû´Ù. °ø´ÜÀº ¿ÃÇØ 1¿ùºÎÅÍ º¸Çè±Þ¿©°¡ Àû¿ëµÇ´Â 8°³ Ç׸ñ¿¡ ´ëÇÑ ¸ð´ÏÅ͸µÀ» ½Ç½ÃÇÑ °á°ú, MRIÀÇ º¸ÇèÀû¿ë Áúȯ, ºÎÀ§, Ƚ¼ö µî¿¡ ´ëÇÑ ¹®Àǰ¡ °¡Àå ¸¹ÀÚ È«º¸ °È¿¡ ³ª¼¹´Ù. °ø´ÜÀº À̹ø Æ÷½ºÅÍ¿Í ¸®Çø´ ¹èÆ÷·Î ±¹¹ÎÀÇ ±Ã±ÝÁõ ÇØ¼Ò¿Í ÀÇ·á±â°ü ¹Î¿øºÎ´ãÀÌ ÁÙ °ÍÀ¸·Î ¿¹»óÇß´Ù. X AD ²ÜÁ¶ÇÕ Ã£¾Æº¸±â! À̺¥Æ®Âü¿© ¡æ Á¤¿õÁ¾ ±âÀÚ(bulddong@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °Çº¸°ø´Ü, MRI º¸ÇèÀû¿ë È«º¸Æ÷½ºÅÍ ¹èÆ÷ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö